Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study (vol 21, 80, 2020)

Tegtmeier, Frank; Schinzel, Reinhard; Beer, Ronny; Bulters, Diederik; LeFrant, Jean-Yves; Sahuquillo, Joan; Unterberg, Andreas; Andrews, Peter; Belli, Antonio; Ibanez, Javier; Lagares, Alfonso; Mokry, Michael; Willschke, Harald; Flueh, Charlotte; Schmutzhard, Erich; NOSTRA Investigators

doi:10.1186/s13063-020-4107-8

Identifier to cite or link to this item: http://hdl.handle.net/20.500.13003/11699

View

000515883600002.pdf (188.6Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/11699

DOI: 10.1186/s13063-020-4107-8

eISSN: 1745-6215

WOS ID: 000515883600002

Scopus EID: 2-s2.0-85079339680

PMID: 32051020

Embase PUI: L630939847

Metrics

Export

External links

Publication date

2020-02-12

Document type

corrigendum

Citation

Tegtmeier F, Schinzel R, Beer R, Bulters D, Lefrant JY, Sahuquillo J, et al. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study (vol 21, 80, 2020) [correction]. Trials. 2020 Feb 12;21(1):172.

Publisher version

https://dx.doi.org/10.1186/s13063-020-4107-8

This item appears in following Docusalut collections

Hospital Universitario Son Espases - HUSE > Comunicación científica

This item's license is described as Attribution 4.0 International